Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vulvar cancer: prognostic factors.
Nicoletto MO, Parenti A, Del Bianco P, Lombardi G, Pedrini L, Pizzi S, Carli P, Della Palma M, Pastorelli D, Corti L, Becagli L. Nicoletto MO, et al. Among authors: del bianco p. Anticancer Res. 2010 Jun;30(6):2311-7. Anticancer Res. 2010. PMID: 20651385
Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.
Lombardi G, Bergo E, Del Bianco P, Bellu L, Pambuku A, Caccese M, Trentin L, Zagonel V. Lombardi G, et al. Among authors: del bianco p. Am J Clin Oncol. 2018 Dec;41(12):1263-1271. doi: 10.1097/COC.0000000000000459. Am J Clin Oncol. 2018. PMID: 29750673 Clinical Trial.
The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.
Pinton L, Masetto E, Vettore M, Solito S, Magri S, D'Andolfi M, Del Bianco P, Lollo G, Benoit JP, Okada H, Diaz A, Della Puppa A, Mandruzzato S. Pinton L, et al. Among authors: del bianco p. J Immunother Cancer. 2019 Feb 27;7(1):58. doi: 10.1186/s40425-019-0536-x. J Immunother Cancer. 2019. PMID: 30813960 Free PMC article.
Immune senescence and immune activation in elderly colorectal cancer patients.
Giunco S, Petrara MR, Bergamo F, Del Bianco P, Zanchetta M, Carmona F, Zagonel V, De Rossi A, Lonardi S. Giunco S, et al. Among authors: del bianco p. Aging (Albany NY). 2019 Jun 13;11(11):3864-3875. doi: 10.18632/aging.102022. Aging (Albany NY). 2019. PMID: 31195370 Free PMC article.
Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic Sarcoma.
Piano MA, Brunello A, Cappellesso R, Del Bianco P, Mattiolo A, Fritegotto C, Montini B, Zamuner C, Del Fiore P, Rastrelli M, Sommariva A, De Salvo GL, Montesco MC, Rossi CR, Zagonel V, Calabrò ML. Piano MA, et al. Among authors: del fiore p, del bianco p. Clin Cancer Res. 2020 Jun 15;26(12):2921-2931. doi: 10.1158/1078-0432.CCR-19-2297. Epub 2020 Mar 3. Clin Cancer Res. 2020. PMID: 32127392
Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis.
Indraccolo S, De Salvo GL, Verza M, Caccese M, Esposito G, Piga I, Del Bianco P, Pizzi M, Gardiman MP, Eoli M, Rudà R, Brandes AA, Ibrahim T, Rizzato S, Lolli I, Zagonel V, Lombardi G. Indraccolo S, et al. Among authors: del bianco p. Clin Cancer Res. 2020 Sep 1;26(17):4478-4484. doi: 10.1158/1078-0432.CCR-19-4055. Epub 2020 Jun 9. Clin Cancer Res. 2020. PMID: 32518098 Clinical Trial.
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters.
Sharova E, Maruzzo M, Del Bianco P, Cavallari I, Pierantoni F, Basso U, Ciminale V, Zagonel V. Sharova E, et al. Among authors: del bianco p. Front Oncol. 2021 Mar 16;11:626104. doi: 10.3389/fonc.2021.626104. eCollection 2021. Front Oncol. 2021. PMID: 33796462 Free PMC article.
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial).
Lombardi G, Del Bianco P, Brandes AA, Eoli M, Rudà R, Ibrahim T, Lolli I, Rizzato S, Daniele B, Pace A, Pasqualetti F, Caccesse M, Bergo E, Magni G, De Salvo GL, Zagonel V. Lombardi G, et al. Among authors: del bianco p. Eur J Cancer. 2021 Sep;155:179-190. doi: 10.1016/j.ejca.2021.06.055. Epub 2021 Aug 10. Eur J Cancer. 2021. PMID: 34388515 Clinical Trial.
193 results